Analyst Price Targets — AORT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 17, 2025 9:31 am | William Plovanic | Canaccord Genuity | $51.00 | $45.91 | StreetInsider | Canaccord Genuity Reiterates Buy Rating on Artivion Inc. (AORT) |
| November 7, 2025 11:11 am | Suraj Kalia | Oppenheimer | $50.00 | $45.73 | StreetInsider | Artivion Inc. (AORT) PT Raised to $50 at Oppenheimer |
| August 8, 2025 11:09 am | Mike Matson | Needham | $45.00 | $39.27 | StreetInsider | Artivion Inc. (AORT) PT Raised to $45 at Needham |
| October 23, 2024 3:32 am | Daniel Stauder | JMP Securities | $33.00 | $26.53 | StreetInsider | JMP Securities Starts Artivion Inc. (AORT) at Market Outperform |
| August 9, 2024 7:52 am | Suraj Kalia | Oppenheimer | $30.00 | $25.33 | StreetInsider | Artivion Inc. (AORT) PT Raised to $30 at Oppenheimer |
| July 10, 2024 9:08 am | Frank Takkinen | Lake Street | $30.00 | $25.94 | TheFly | Lake Street highlights five 'bargain bin' small cap healthcare ideas for 2H |
| July 2, 2024 8:49 am | Frank Takkinen | Loop Capital Markets | $30.00 | $26.02 | StreetInsider | Artivion Inc. (AORT) PT Raised to $30 at Lake Street Capital Markets |
| May 7, 2024 5:56 am | Mike Matson | Needham | $30.00 | $21.07 | StreetInsider | Artivion Inc. (AORT) PT Raised to $30 at Needham |
Latest News for AORT
ATLANTA, March 3, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate virtually at the upcoming Oppenheimer 36th Annual Healthcare MedTech & Services Conference. The Company's virtual fireside chat is scheduled to begin at 9:20 a.m.
Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript
Artivion (AORT) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to break-even earnings per share a year ago.
Fourth Quarter Highlights: GAAP revenue was $116.0 million in the fourth quarter of 2025 versus $97.3 million in the fourth quarter of 2024. For the full year, GAAP revenue was $441.3 million versus $388.5 million for the full year of 2024.
Artivion (NYSE: AORT - Get Free Report) is expected to announce its Q4 2025 results after the market closes on Thursday, February 12th. Analysts expect the company to announce earnings of $0.14 per share and revenue of $116.4190 million for the quarter. Investors can check the company's upcoming Q4 2025 earning summary page for the latest
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.